Drug profile · INN
cabazitaxel
CABAZITAXEL ACCORD
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
cabazitaxel (CABAZITAXEL ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN cabazitaxel
Brand CABAZITAXEL ACCORD
Route INJECTION
Formulation INJECTABLE
ATC code L01CD04
Originator Teva Pharma GmbH
Related patents
Search patents →Frequently asked questions
What is cabazitaxel?
cabazitaxel (CABAZITAXEL ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cabazitaxel?
CABAZITAXEL ACCORD is a marketed brand name for cabazitaxel. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cabazitaxel?
cabazitaxel has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.